Science Immunology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2020-10-11 charlene0316

editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭

271 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2022-02-26 MAC1234

审稿速度:3.0
经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过

88 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2023-04-07 ms7000001335611101 来自天津

偏重的研究方向：免疫学
经验分享：投稿分享 4-4投稿 4-5 Under Evaluation

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2022-10-20 csw1314527

偏重的研究方向：innate immunity
经验分享：under evaluation 两周了，请问下大神这是什么情况

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2022-02-18 ms1000001479366679

审稿速度:6.0
经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2021-01-13 丿柚子

收不收综述？

136 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2022-09-06 guolihuihelan_91618321

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：covid-19
经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看

54 0

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2019-03-14 sunliang

有好的稿子赶紧投，潜力股啊

316 0

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2019-02-20 sunliang

是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表:
Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。

Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。

516 0

[GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0 经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学 经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity 经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0 经验分享：投稿3个月了邮件问说还在初步审稿没送审，速度很慢呀有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：covid-19 经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566774, encodeId=3b4e566e7417, content=Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=638, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Fri Feb 15 00:00:00 CST 2019, time=2019-02-15, status=1, ipAttribution=)]

2019-02-15 Leopard FD

Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。

638 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务